$2,534,948
－6.1%
Former Chief Executive Officer
2023
$2.5M
40 hrs/wk
Former Chief Executive Officer at Transcelerate Biopharma Inc.
Fiscal year ended December 31, 2023. Published on January 25, 2026.
Total compensation
Dalvir Gill has been listed as an employee of Transcelerate Biopharma Inc. in Form 990 filings since at least fiscal year 2016. Total compensation for Dalvir Gill has increased by 60.5% from 2016 to 2023.